Hairy cell leukemia overview: Difference between revisions
Created page with "{{Hairy cell leukemia}} {{CMG}} ==Overview== ==References== {{reflist|2}} Category:Disease Category:Types of cancer Category:Hematology Category:Oncology ..." |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
'''Hairy cell leukemia''' is a mature B cell [[neoplasm]]. It is usually classified as a sub-type of [[chronic lymphoid leukemia]] for convenience. It is uncommon, representing about 2% of all leukemias, or less than a total of 2000 new cases diagnosed each year in the North America and Western Europe combined. | |||
Originally known as histiocytic leukemia, malignant reticulosis, or lymphoid myelofibrosis in publications dating back to the 1920s, this disease was formally named leukemic reticuloendotheliosis and its characterization significantly advanced by Bertha Bouroncle, M.D., and her colleagues at the [[OSU College of Medicine and Public Health|Ohio State University College of Medicine]] in 1958. Its common name, which was coined in 1966<ref>{{cite web |url=http://bloodjournal.hematologylibrary.org/cgi/content/abstract/27/2/199 |title="Hairy" Cells in Blood in Lymphoreticular Neoplastic Disease and "Flagellated" Cells of Normal Lymph Nodes -- SCHREK and DONNELLY 27 (2): 199 -- Blood |accessdate=2007-09-10 |format= |work=}}</ref>, is derived from the appearance of the cells under a microscope. | |||
==References== | ==References== | ||
Revision as of 16:52, 21 January 2012
|
Hairy cell leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hairy cell leukemia overview On the Web |
|
American Roentgen Ray Society Images of Hairy cell leukemia overview |
|
Risk calculators and risk factors for Hairy cell leukemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hairy cell leukemia is a mature B cell neoplasm. It is usually classified as a sub-type of chronic lymphoid leukemia for convenience. It is uncommon, representing about 2% of all leukemias, or less than a total of 2000 new cases diagnosed each year in the North America and Western Europe combined.
Originally known as histiocytic leukemia, malignant reticulosis, or lymphoid myelofibrosis in publications dating back to the 1920s, this disease was formally named leukemic reticuloendotheliosis and its characterization significantly advanced by Bertha Bouroncle, M.D., and her colleagues at the Ohio State University College of Medicine in 1958. Its common name, which was coined in 1966[1], is derived from the appearance of the cells under a microscope.